亚太代谢组学服务市场预测至 2028 年 - 按服务类型(靶向代谢组学服务和非靶向代谢组学服务)和应用(制药和生物技术行业、农业技术和环境)划分的 COVID-19 影响和区域分析

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 138    |    Report Code: TIPRE00026146    |    Category: Life Sciences

Asia Pacific Metabolomics Services Market

市场介绍

亚太地区 (APAC) 是代谢组学增长最快的区域市场服务;中国、印度、日本、韩国、澳大利亚和亚太地区其他国家是该地区市场的主要贡献者。由于国际参与者在中国和印度的投资不断增加、各国政府支持的改善、CRO服务基础的扩大以及医疗基础设施的进步,亚太地区可能在2021年占据全球代谢组学服务市场超过25.68%的市场份额。因此,该地区代谢组学服务市场参与者在预测期内具有巨大的增长潜力。日本医疗保健行业正在见证巨大的发展和财政援助,以加速其基于细胞疗法的产品的采用和接受。政府专注于制定法律和政策,以支持再生医学等新型诊断和治疗方法的创新和发现。该国拥有合同研究组织,这反过来又有望支持市场增长。相关市场的参与者正在积极投资日本。多个国家的发展机会是推动亚太地区代谢组学服务市场增长的主要因素。

由于持续的 COVID-19 大流行,医疗保健行业面临着巨大的压力。压力。遏制和社会疏远措施导致供应链中断。此外,对 COVID-19 的有效诊断和治疗的需求在亚太地区变得至关重要。印度、中国、日本和韩国等该地区国家因疫情而遭受各种不利影响,包括社会经济受损、通货膨胀、国内生产总值低迷和失业率激增。中国、日本、新加坡和韩国等国家开展了快速临床试验。西方国家的高运营成本推动医疗事务外包流向亚太地区。为了利用这些机会,该地区的制药公司获得了有关药物、设备和体外诊断的新的和不断变化的监管环境的专业知识。亚洲经常实施新的或改进的法规,包括 GMP 标准、药品价格控制和医疗器械监管体系的变化。任何新标准的获取或改进都需要第三方的指导和建议。第三方外包服务提供商在支持亚太地区相关市场方面发挥着越来越重要的作用。截至 2021 年,由于控制程序、人们的意识、疫苗开发和管理以及促进业务增长的政府支持政策,市场已经稳定。

市场概况和动态

亚太地区代谢组学服务市场预计将从2021年的1.1042亿美元增长到2028年的4.3891亿美元;预计 2021 年至 2028 年复合年增长率为 21.8%。代谢组学是检测组织和生物体液中各种代谢物的不断发展且强大的技术之一。该过程在与癌症疾病相关的分析和研究中具有重要的应用。不同类型癌症患病率的上升预计将在预测期内推动市场发展。癌症诊断在癌症治疗中发挥着重要作用。根据世界卫生组织 (WHO) 2021 年 9 月发布的数据,近 70% 的癌症死亡病例来自该地区的低收入和中等收入国家。因此,癌症发病率的上升预计将激增代谢组学服务的需求,从而推动市场增长。

关键细分市场< /strong>

亚太地区代谢组学服务市场已根据服务类型、应用和国家/地区进行细分。根据服务类型,亚太地区代谢组学服务市场分为靶向代谢组学服务和非靶向代谢组学服务。目标代谢组学服务领域在 2020 年占据市场主导地位,预计将在预测期内增长最快。根据应用,市场分为制药和生物技术行业、农业技术和环境。制药和生物技术行业在 2020 年占据市场主导地位,预计将在预测期内增长最快。同样,制药和生物技术行业细分为生物标志物发现、药物发现、毒理学测试等。

主要来源和上市公司

u>

准备本亚太地区代谢组学服务市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家报告、政府文件、统计数据库等。报告中列出的主要公司包括 BASF SE、BGI、biocrates life sciences ag、C-CAMP、Chenomx Inc.、Creative Proteomics、Fred Hutchinson Cancer Research Center 和 RTI International 等。 span>

购买报告的理由

  • 了解亚太地区代谢组学服务市场格局,并确定最有可能保证丰厚回报的细分市场
  • 保持领先地位了解亚太地区代谢组学服务市场不断变化的竞争格局
  • 通过识别最有前景的细分市场,有效规划亚太地区代谢组学服务市场的并购和合作交易销售
  • 通过对亚太地区代谢组学服务市场各个细分市场表现的敏锐和全面的分析,帮助做出明智的业务决策
  • 获取亚太地区 2021-2028 年各细分市场的市场收入预测

亚太地区代谢组学服务市场细分

亚太地区代谢组学服务市场 - 按

服务类型

  • 靶向代谢组学服务
  • 非靶向代谢组学服务

亚太地区代谢组学服务市场 - 按应用

  • 制药和生物技术行业
    • 生物标志物发现
    • 药物发现
    • 毒理学测试
    • 其他
  • 农业科技
  • 环境

亚太地区代谢组学服务市场 - 按国家/地区

  • 日本
  • 中国
  • 印度 span>
  • 澳大利亚
  • 韩国
  • 亚太地区其他地区

亚太地区代谢组学服务市场 -

公司简介

< /span>

  • 巴斯夫股份公司
  • 华大基因
  • biocrates生命科学ag
  • C-CAMP
  • Chenomx Inc.
  • 创意蛋白质组学
  • 弗雷德·哈钦森癌症研究中心
  • RTI国际


Asia Pacific Metabolomics Services Strategic Insights

Strategic insights for Asia Pacific Metabolomics Services involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-metabolomics-services-market-strategic-framework.webp
Get more information on this report

Asia Pacific Metabolomics Services Report Scope

Report Attribute Details
Market size in 2021 US$ 110.42 Million
Market Size by 2028 US$ 438.91 Million
Global CAGR (2021 - 2028) 21.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 服务类型
  • 靶向代谢组学服务和非靶向代谢组学服务
By 应用
  • 制药和生物技术行业
  • 农业技术
  • 环境
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • BASF SE
  • BGI
  • biocrates life sciences ag
  • C-CAMP
  • Chenomx Inc.
  • Creative Proteomics
  • Fred Hutchinson Cancer Research Center
  • RTI International
  • Get more information on this report

    Asia Pacific Metabolomics Services Regional Insights

    The regional scope of Asia Pacific Metabolomics Services refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-metabolomics-services-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Metabolomics Services Market

    1. BASF SE
    2. BGI
    3. biocrates life sciences ag
    4. C-CAMP
    5. Chenomx Inc.
    6. Creative Proteomics
    7. Fred Hutchinson Cancer Research Center
    8. RTI International
    Frequently Asked Questions
    How big is the Asia Pacific Metabolomics Services Market?

    The Asia Pacific Metabolomics Services Market is valued at US$ 110.42 Million in 2021, it is projected to reach US$ 438.91 Million by 2028.

    What is the CAGR for Asia Pacific Metabolomics Services Market by (2021 - 2028)?

    As per our report Asia Pacific Metabolomics Services Market, the market size is valued at US$ 110.42 Million in 2021, projecting it to reach US$ 438.91 Million by 2028. This translates to a CAGR of approximately 21.8% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Metabolomics Services Market report typically cover these key segments-

  • 服务类型 (靶向代谢组学服务和非靶向代谢组学服务)
  • 应用 (制药和生物技术行业, 农业技术, 环境)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Metabolomics Services Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Metabolomics Services Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Metabolomics Services Market?

    The Asia Pacific Metabolomics Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • BASF SE
  • BGI
  • biocrates life sciences ag
  • C-CAMP
  • Chenomx Inc.
  • Creative Proteomics
  • Fred Hutchinson Cancer Research Center
  • RTI International
  • Who should buy this report?

    The Asia Pacific Metabolomics Services Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Metabolomics Services Market value chain can benefit from the information contained in a comprehensive market report.